Yadav Mukesh K, Sharma Madhurima, Lal Anupam, Gupta Vivek, Sharma Ashish, Khandelwal Niranjan
Department of Radiodiagnosis and Imaging, Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab and Haryana, India.
Department of Transplant Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab and Haryana, India.
Indian J Radiol Imaging. 2015 Oct-Dec;25(4):368-74. doi: 10.4103/0971-3026.169463.
Central venous disease is a serious complication in patients undergoing hemodialysis, often presenting with symptoms of venous hypertension. Treatment is aimed to provide symptomatic relief and to maintain hemodialysis access site patency.
To describe our initial experience in the endovascular treatment of central venous stenosis or obstruction in patients undergoing hemodialysis.
This was a retrospective study carried out in a tertiary care center. Study duration was 24 months. Follow-up was variable.
Eleven patients of chronic renal failure undergoing hemodialysis presented with central vein stenosis or obstruction having ipsilateral vascular access, between July 2012 and July 2014. All the patients underwent endovascular treatment and were analyzed retrospectively.
A total of 11 patients (4 male and 7 female) underwent 18 interventions for 13 stenotic segments during a time period of 2 years. Eight stenotic segments were in brachiocephalic vein, three in subclavian vein, and two in axillary veins. The technical success rate for endovascular treatment was 81.8%. Two patients underwent percutaneous transluminal angioplasty (PTA) alone and presented with restenosis later. Balloon angioplasty followed by stenting was done in seven patients, two of which required reintervention during follow-up. We found endovascular treatment safe and effective in treating central venous disease.
中心静脉疾病是血液透析患者的一种严重并发症,常表现为静脉高压症状。治疗旨在缓解症状并维持血液透析通路的通畅。
描述我们在血液透析患者中心静脉狭窄或阻塞的血管内治疗方面的初步经验。
这是一项在三级医疗中心进行的回顾性研究。研究持续时间为24个月。随访情况不一。
2012年7月至2014年7月期间,11例接受血液透析的慢性肾衰竭患者出现中心静脉狭窄或阻塞并伴有同侧血管通路。所有患者均接受了血管内治疗并进行回顾性分析。
在2年时间里,共有11例患者(4例男性和7例女性)针对13个狭窄节段进行了18次干预。8个狭窄节段位于头臂静脉,3个位于锁骨下静脉,2个位于腋静脉。血管内治疗的技术成功率为81.8%。2例患者仅接受了经皮腔内血管成形术(PTA),随后出现再狭窄。7例患者进行了球囊血管成形术并置入支架,其中2例在随访期间需要再次干预。我们发现血管内治疗在治疗中心静脉疾病方面安全有效。